Palliative Care for Patients With Cancer: ASCO Guideline Update.


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
15 May 2024
Historique:
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 15 5 2024
Statut: aheadofprint

Résumé

To provide evidence-based guidance to oncology clinicians, patients, nonprofessional caregivers, and palliative care clinicians to update the 2016 ASCO guideline on the integration of palliative care into standard oncology for all patients diagnosed with cancer. ASCO convened an Expert Panel of medical, radiation, hematology-oncology, oncology nursing, palliative care, social work, ethics, advocacy, and psycho-oncology experts. The Panel conducted a literature search, including systematic reviews, meta-analyses, and randomized controlled trials published from 2015-2023. Outcomes of interest included quality of life (QOL), patient satisfaction, physical and psychological symptoms, survival, and caregiver burden. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. The literature search identified 52 relevant studies to inform the evidence base for this guideline. Evidence-based recommendations address the integration of palliative care in oncology. Oncology clinicians should refer patients with advanced solid tumors and hematologic malignancies to specialized interdisciplinary palliative care teams that provide outpatient and inpatient care beginning early in the course of the disease, alongside active treatment of their cancer. For patients with cancer with unaddressed physical, psychosocial, or spiritual distress, cancer care programs should provide dedicated specialist palliative care services complementing existing or emerging supportive care interventions. Oncology clinicians from across the interdisciplinary cancer care team may refer the caregivers (eg, family, chosen family, and friends) of patients with cancer to palliative care teams for additional support. The Expert Panel suggests early palliative care involvement, especially for patients with uncontrolled symptoms and QOL concerns. Clinicians caring for patients with solid tumors on phase I cancer trials may also refer them to specialist palliative care.Additional information is available at www.asco.org/supportive-care-guidelines.

Identifiants

pubmed: 38748941
doi: 10.1200/JCO.24.00542
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

JCO2400542

Auteurs

Justin J Sanders (JJ)

McGill University, Montreal, Canada.

Sarah Temin (S)

American Society of Clinical Oncology (ASCO), Alexandria, VA.

Arun Ghoshal (A)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Erin R Alesi (ER)

Virginia Commonwealth University Health System, Massey Cancer Center, Richmond, VA.

Zipporah Vunoro Ali (ZV)

Kenya Hospices and Palliative Care Association, Nairobi, Kenya.

Cynthia Chauhan (C)

Mayo Clinic Breast SPORE, Wichita, KS.

James F Cleary (JF)

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN.

Andrew S Epstein (AS)

Memorial Sloan Kettering Cancer Center, New York, NY.

Janice I Firn (JI)

University of Michigan, Ann Arbor, MI.

Joshua A Jones (JA)

Rochester Regional Health, Rochester, NY.

Debra Lundquist (D)

Massachusetts General Hospital, Boston, MA.

Mabel Alejandra Mardones (MA)

Rocky Mountain Cancer Center-Denver Midtown, Denver, CO.

Ryan David Nipp (RD)

OU Health Stephenson Cancer Center, Oklahoma City, OK.

Michael W Rabow (MW)

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

William E Rosa (WE)

Memorial Sloan Kettering Cancer Center, New York, NY.

Camilla Zimmermann (C)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Betty R Ferrell (BR)

City of Hope National Medical Center, Duarte, CA.

Classifications MeSH